Form 8-K - Current report:
SEC Accession No. 0001193125-21-014788
Filing Date
2021-01-22
Accepted
2021-01-22 16:29:34
Documents
12
Period of Report
2021-01-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d113224d8k.htm   iXBRL 8-K 22690
  Complete submission text file 0001193125-21-014788.txt   140401

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210121.xsd EX-101.SCH 3081
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210121_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210121_pre.xml EX-101.PRE 10960
5 EXTRACTED XBRL INSTANCE DOCUMENT d113224d8k_htm.xml XML 3271
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

EIN.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 21546121
SIC: 2834 Pharmaceutical Preparations